---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-031504"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2021-12-15T23:59:59+00:00"
generated_at: "2026-06-28T01:04:05.540648+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sanara MedTech appoints Roszell Mack III to Board effective January 1, 2022

## Summary
- Board expanded from 7 to 8 directors; Mack fills newly created vacancy effective Jan 1, 2022.
- Mack is President of Mack & Co., LLC, with investment banking experience at Goldman Sachs and Salomon Smith Barney.
- Mack appointed to audit committee; eligible for annual restricted stock grants valued at $90,000.
- Executive Chairman Ron Nixon cites Mack's finance and venture scaling expertise as valuable to growth plans.

## SEC filing metadata
- accession: 0001493152-21-031504
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2021-12-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315221031504/0001493152-21-031504-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315221031504/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-031504
- JSON: https://secwatch.observer/filing/0001493152-21-031504.json
- Plain text: https://secwatch.observer/filing/0001493152-21-031504.txt

## Key facts
- Executive change
  Roszell Mack III was appointed as Director at Sanara MedTech Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Roszell Mack III as a director of the Company to fill the newly created vacancy, effective January 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315221031504/0001493152-21-031504-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.